Clinical Trial Update: Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease. [Phase 2]

View source ↗

Summary

A Phase 2 efficacy and safety trial of NV1FGF in patients with severe peripheral artery disease has completed, with an update on the trial outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• NV1FGF (NV1FGF)

Snippet

Sponsor: Sanofi | Conditions: Severe Peripheral Artery Occlusive Disease | Phase 2 | Status: COMPLETED